XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Non-Controlling Interest
Beginning balance (in shares) at Dec. 31, 2022   289,014,487        
Beginning balance at Dec. 31, 2022 $ 573,454 $ 2,890 $ 1,030,466 $ (89,740) $ (370,866) $ 704
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 147,202       147,202  
Other comprehensive income (loss) (5,388)     (5,388)    
Dividends declared 43,992       43,992  
Shares issued in connection with deferred compensation plan, net (in shares)   2,845,448        
Shares issued in connection with deferred compensation plan, net (38,456) $ 28 (28)   (38,456)  
Deferred compensation plan elective participant deferrals 1,712   1,712      
Shares issued in connection with executive bonus plan, net (in shares)   171,510        
Shares issued in connection with executive bonus plan, net 7,301 $ 2 13,055   (5,756)  
Shares issued in connection with employee stock purchase plan, net (in shares)   315,840        
Shares issued in connection with employee stock purchase plan, net 9,143 $ 3 9,985   (845)  
Stock option exercises, net (in shares)   2,422,082        
Stock option exercises, net 4,182 $ 24 10,566   (6,408)  
Shares issued for stock grants, net (in shares)   12,639        
Shares issued for stock grants, net 600   600      
Stock-based compensation expense 42,465   42,465      
Shares related to restricted stock, net (in shares)   462,200        
Shares related to restricted stock, net (6,062) $ 5 (5)   (6,062)  
Ending balance (in shares) at Sep. 30, 2023   295,244,206        
Ending balance at Sep. 30, 2023 692,161 $ 2,952 1,108,816 (95,128) (325,183) 704
Beginning balance (in shares) at Jun. 30, 2023   294,712,983        
Beginning balance at Jun. 30, 2023 643,772 $ 2,947 1,085,066 (87,828) (357,117) 704
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 53,027       53,027  
Other comprehensive income (loss) (7,300)     (7,300)    
Dividends declared 14,768       14,768  
Shares issued in connection with deferred compensation plan, net (in shares)   63,267        
Shares issued in connection with deferred compensation plan, net (2,127)       (2,127)  
Deferred compensation plan elective participant deferrals 61   61      
Shares issued in connection with executive bonus plan, net (in shares)   34,313        
Shares issued in connection with executive bonus plan, net 1,821   3,251   (1,430)  
Shares issued in connection with employee stock purchase plan, net (in shares)   162,459        
Shares issued in connection with employee stock purchase plan, net 4,808 $ 2 5,429   (623)  
Stock option exercises, net (in shares)   185,255        
Stock option exercises, net 471 $ 2 888   (419)  
Stock-based compensation expense 14,122   14,122      
Shares related to restricted stock, net (in shares)   85,929        
Shares related to restricted stock, net (1,726) $ 1 (1)   (1,726)  
Ending balance (in shares) at Sep. 30, 2023   295,244,206        
Ending balance at Sep. 30, 2023 692,161 $ 2,952 1,108,816 (95,128) (325,183) 704
Beginning balance (in shares) at Dec. 31, 2023   296,265,837        
Beginning balance at Dec. 31, 2023 883,982 $ 2,963 1,127,234 (84,987) (161,932) 704
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 184,694       184,694  
Other comprehensive income (loss) 2,028     2,028    
Dividends declared 53,985       53,985  
Shares issued in connection with deferred compensation plan, net (in shares)   4,655,277        
Shares issued in connection with deferred compensation plan, net 0 $ 46 (46)      
Deferred compensation plan elective participant deferrals 144   144      
Shares issued in connection with executive bonus plan, net (in shares)   256,587        
Shares issued in connection with executive bonus plan, net 13,199 $ 3 13,196      
Shares issued in connection with employee stock purchase plan, net (in shares)   253,578        
Shares issued in connection with employee stock purchase plan, net 10,880 $ 2 11,226   (348)  
Stock option exercises, net (in shares)   844,283        
Stock option exercises, net 1,812 $ 8 3,999   (2,195)  
Shares issued for stock grants, net (in shares)   11,391        
Shares issued for stock grants, net 600   600      
Stock-based compensation expense 45,096   45,096      
Shares related to restricted stock, net (in shares)   668,586        
Shares related to restricted stock, net (8,671) $ 7 (7)   (8,671)  
Repurchases of Class B common stock under approved program (in shares)   (912,737)        
Repurchases of Class B common stock under approved program (45,769) $ (9)     (45,760)  
Ending balance (in shares) at Sep. 30, 2024   302,042,802        
Ending balance at Sep. 30, 2024 1,034,010 $ 3,020 1,201,442 (82,959) (88,197) 704
Beginning balance (in shares) at Jun. 30, 2024   299,747,133        
Beginning balance at Jun. 30, 2024 984,506 $ 2,997 1,176,630 (93,264) (102,561) 704
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 42,338       42,338  
Other comprehensive income (loss) 10,305     10,305    
Dividends declared 18,134       18,134  
Shares issued in connection with deferred compensation plan, net (in shares)   2,181,214        
Shares issued in connection with deferred compensation plan, net 0 $ 22 (22)      
Deferred compensation plan elective participant deferrals 43   43      
Shares issued in connection with executive bonus plan, net (in shares)   88,296        
Shares issued in connection with executive bonus plan, net 4,283 $ 1 4,282      
Shares issued in connection with employee stock purchase plan, net (in shares)   131,558        
Shares issued in connection with employee stock purchase plan, net 5,495 $ 1 5,667   (173)  
Stock-based compensation expense 14,843   14,843      
Shares related to restricted stock, net (in shares)   77,657        
Shares related to restricted stock, net (1,415) $ 1 (1)   (1,415)  
Repurchases of Class B common stock under approved program (in shares)   (183,056)        
Repurchases of Class B common stock under approved program (8,254) $ (2)     (8,252)  
Ending balance (in shares) at Sep. 30, 2024   302,042,802        
Ending balance at Sep. 30, 2024 $ 1,034,010 $ 3,020 $ 1,201,442 $ (82,959) $ (88,197) $ 704